Impact/ESG

Improving the lives ofpatients

We strive to integrate ESG principles and best practices across all our activities, as well as those of our portfolio companies.

Ysios has been dedicated to improving patients’ lives by supporting innovative biotech companies since 2008

Our commitment

At Ysios Capital, we’re committed to investing in diverse and environmentally conscious companies , we do care about how our companies are managed. To this end, we have created a detailed questionnaire to monitor the ESG performance of current and potential portfolio companies.

In addition, as all advancements first require an understanding of the data, the Ysios team has created a new tool to measure impact and focus on the most impactful companies.

Y-Score impact assessment

Our ESG Report

Ysios Capital’s first ESG report highlights our journey of integrating ESG principles into our investment approach. Since signing the UNPRI in 2015, we’ve embedded these values into our processes, supporting transformative therapies that improve lives and deliver lasting impact.

Explore the report to learn how our ESG practices drive innovation in life sciences.

ESG Report 2024

3 verticals of commitment

1 - Promoting health & well being

We have a positive impact on patients and society by funding the development of novel therapies for indications with a high unmet medical need.

Actively supporting patients’ associations on an annual basis by committing budget to selected projects.

41

Companies financed

1B

patients could benefit from these therapies

19

products brought to market

14

medicines under development addressing rare diseases

15

medicines under development addressing conditions with high mortality/morbidity

22

medicines under development addressing diseases with no current treatment

2 - Enhancing the diversity of the workforce in the industry

More diverse teams deliver better results. We promote inclusion and a culture of unbiased decision-making both in-house and in our portfolio companies.

Collaborating with Women2Invest, promoting female STEM (Science, Technology, Engineering and Mathematics) profiles in the VC/PE industry.

Structured process for unbiased hiring.

Tracking and increasing diversity of portfolio companies by requiring all selection processes to include diverse candidates, increasing network to provide candidates from underrepresented groups, encouraging diversity training.